USPH — US Physical Therapy Cashflow Statement
0.000.00%
Last trade - 00:00- $1.12bn
- $1.54bn
- $780.99m
Annual cashflow statement for US Physical Therapy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 57.9 | 43.4 | 37.2 | 45.6 | 58 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 12.9 | 17.5 | 32.1 | 17.6 | 9.12 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.7 | -21.4 | -7.51 | -12.3 | -25.9 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 76.4 | 58.5 | 82 | 74.9 | 75.1 |
| Capital Expenditures | -8.2 | -8.25 | -9.29 | -9.19 | -14.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -116 | -73 | -35.7 | -140 | -22.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -124 | -81.3 | -45 | -149 | -36.7 |
| Financing Cash Flow Items | -31 | -17.1 | -16.1 | -14.7 | -19.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 43.4 | 25.8 | 84.3 | -37 | -44.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.35 | 3.03 | 121 | -111 | -5.79 |